FDA Issues Warning Letter to Sklar Personal Care
December 17, 2025
December 17, 2025
WASHINGTON, Dec. 17 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Sklar Personal Care Inc. from the Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Ross Sklar, Chief Executive Officer, Sklar Personal Care Inc., 3137 East 26th Street, Vernon, CA 90058, United States, Ross@starcobrands.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
. . .
* * *
Recipient: Mr. Ross Sklar, Chief Executive Officer, Sklar Personal Care Inc., 3137 East 26th Street, Vernon, CA 90058, United States, Ross@starcobrands.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
. . .
